万基遗传

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002082246-25-000008  Size: 4 KB 网页链接

$万基遗传(MYGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000312069-25-000583  Act: 34  Size: 6 KB 网页链接

$万基遗传(MYGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-110358  Act: 34  Size: 19 KB 网页链接

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843872-26-000003  Size: 5 KB 网页链接

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001738340-25-000009  Size: 4 KB 网页链接

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001922964-26-000002  Size: 4 KB 网页链接

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002082246-26-000002  Size: 5 KB 网页链接

$万基遗传(MYGN)$ Glenview Capital Management, LLC及其首席执行官Larry Robbins已报告了他们对Myriad Genetics Inc.受益所有权的变更。截至2026年1月12日，他们共同持有4,941,058股普通股，约占已发行股份的5.30%。这些所有权分布在三个基金中：Glenview Capital Master Fund、Glenview Offshore...

$万基遗传(MYGN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000905148-26-000161  Act: 34  Size: 18 KB 网页链接

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001922964-26-000004  Size: 5 KB 网页链接

$万基遗传(MYGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000899923-26-000003  Act: 34  Size: 261 KB 网页链接

$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001517026-26-000002  Size: 5 KB 网页链接